Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
Tngf1te2LgrFx149